Hospital Universitario 12 de Octubre-ko ikertzaileekin lankidetzan egindako argitalpenak (21)

2024

  1. A personalised delisting strategy enables successful kidney transplantation in highly sensitised patients with preformed donor-specific anti HLA antibodies

    HLA, Vol. 103, Núm. 6

2021

  1. Beta-2-Glycoprotein-I Deficiency Could Precipitate an Antiphospholipid Syndrome-like Prothrombotic Situation in Patients With Coronavirus Disease 2019

    ACR Open Rheumatology, Vol. 3, Núm. 4, pp. 267-276

2017

  1. Complement C3F allotype synthesized by liver recipient modifies transplantation outcome independently from donor hepatic C3

    Clinical Transplantation, Vol. 31, Núm. 1

2016

  1. High proportion of CD95+ and CD38+ in cultured CD8+ T cells predicts acute rejection and infection, respectively, in kidney recipients

    Transplant Immunology, Vol. 34, pp. 33-41

2015

  1. Association of early kidney allograft failure with preformed IgA antibodies to β2-glycoprotein I

    Journal of the American Society of Nephrology, Vol. 26, Núm. 3, pp. 735-745

2014

  1. Informe del Taller Ibérico de Histocompatibilidad 2013. Componente de análisis de situación de procedimiento de pruebas cruzadas en guardias de trasplante de órganos

    Inmunologia, Vol. 33, Núm. 1, pp. 27-33

  2. Renal transplantation dramatically reduces IgA anti-beta-2-glycoprotein i antibodies in patients with endstage renal disease

    Journal of Immunology Research, Vol. 2014

2013

  1. Reunión anual del Grupo Español de trabajo en histocompatibilidad e inmunología del trasplante 2012. Estandarización de informes clínicos de sensibilización por anticuerpos anti-antígeno leucocitario humano

    Inmunologia

2012

  1. Complement C3 genotyping of slow and fast variants by real time PCR-high resolution melting

    European Journal of Inflammation, Vol. 10, Núm. 3, pp. 329-334

  2. Informe del Taller Ibérico de Histocompatibilidad 2012. Componente de estandarización de resultados de anticuerpos anti-HLA mediante ensayo en fase sólida

    Inmunologia

  3. Prospective study of biomarkers of immune response in lung transplant recipients

    Transplantation Proceedings

2009

  1. An In Vitro Model of Cell Transplantation for Evaluation of Cell Engraftment Enhancers

    Transplantation Proceedings, Vol. 41, Núm. 6, pp. 2487-2490

2008

  1. Preformed antibodies detected by cytotoxic assay or multibead array decrease liver allograft survival: Role of human leukocyte antigen compatibility

    Liver Transplantation, Vol. 14, Núm. 4, pp. 554-562

2007

  1. Rapid molecular prenatal diagnosis of ataxia-telangiectasia by direct mutational analysis

    Prenatal Diagnosis, Vol. 27, Núm. 9, pp. 861-864

2005

  1. Human leukocyte antigen haplotypes and HFE mutations in Spanish hereditary hemochromatosis and sporadic porphyria cutanea tarda

    Journal of Gastroenterology and Hepatology (Australia), Vol. 20, Núm. 3, pp. 456-462

  2. Rapid molecular diagnosis of ataxia-telangiectasia by optimised RT-PCR and direct sequencing analysis

    Immunobiology, Vol. 210, Núm. 5, pp. 279-282

2004

  1. HLA haplotypes associated with hemochromatosis mutations in the Spanish population

    BMC Medical Genetics, Vol. 5

2000

  1. Evolution of MHC-G in humans and primates based on three new 3′UT polymorphisms

    Human Immunology

1999

  1. The most frequent HFE allele linked to porphyria cutanea tarda in mediterraneans is His63Asp [1]

    Hepatology

1998

  1. Transcription and weak expression of HLA-DRB6: A gene with anomalies in exon 1 and other regions

    Immunogenetics, Vol. 48, Núm. 1, pp. 16-21